AUNAHealthcare · Medical Care FacilitiesAUNA Stock Forecast: Auna SA Price Predictions for 2026-2027
The 7 Wall Street analysts covering Auna SA hold a median 12-month price target of $6.9 — +31.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 56 of 100 as at 1 Aug 2026 — in the upper half.
AUNA stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Auna SA on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (96): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Issuance (31): The company has been issuing shares or taking on financing, diluting existing holders.
The rank is the raw material. Whether the rules would actually own Auna SA — and when they’d sell — is the membership.
AUNA stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on AUNA, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +31.4% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 26 May 2026 | JP Morgan | Maintains | Neutral | $6.00 → $5.00 |
| 26 May 2026 | JP Morgan | Maintains | Neutral | — |
| 16 Jan 2026 | Jefferies | Initiates | Buy | — |
| 18 Nov 2025 | JP Morgan | Downgrade | Neutral | — |
| 11 Feb 2025 | JP Morgan | Maintains | Overweight | — |
| 20 Sept 2024 | JP Morgan | Maintains | Overweight | — |
| 20 Aug 2024 | JP Morgan | Maintains | Overweight | — |
| 23 Apr 2024 | HSBC | Initiates | Buy | — |
| 16 Apr 2024 | Citigroup | Initiates | Buy | — |
| 16 Apr 2024 | JP Morgan | Initiates | Overweight | — |
| 16 Apr 2024 | Morgan Stanley | Initiates | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
AUNA analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Auna SA (AUNA) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 18.8×
- Price / sales
- 0.1×
- Price / book
- 0.8×
- EV / EBITDA
- 5.0×
Cheaper than 41% of US stocks
Cheaper than 97% of US stocks
Cheaper than 79% of US stocks
Cheaper than 54% of US stocks
- Revenue growth (YoY)
- 13.0%
- Earnings growth (YoY)
- −81.5%
- Gross margin
- 36.6%
- Operating margin
- 13.2%
- Net margin
- 1.5%
Higher than 61% of US stocks
Higher than 4% of US stocks
Higher than 46% of US stocks
Higher than 71% of US stocks
Higher than 50% of US stocks
- Return on equity
- 4.6%
- Return on assets
- 5.4%
- Dividend yield
- —
Higher than 53% of US stocks
Higher than 79% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
AUNA vs competitors
The nearest names by industry and size, scored by the same model — like for like.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AUNA appears on the weeks it earns a place.
Frequently asked questions about AUNA stock
What is the AUNA stock price forecast for 2026-2027?
The 7 Wall Street analysts covering Auna SA have a median 12-month price target of $6.9, with estimates ranging from $5 to $9. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is AUNA stock a buy right now?
Of the 7 analysts covering Auna SA, 5 rate it a Buy, 2 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Auna SA 56 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank AUNA?
As at 1 Aug 2026, Auna SA ranks 56 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (96 of 100).
Will AUNA stock go up?
No one can know that. What the data says: the median 12-month target from 7 analysts implies +31.4% from the last close, and Ticker Nerd's factor model ranks Auna SA 56 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the AUNA stock forecast for 2030?
No analyst covering Auna SA publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AUNA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $5 to $9 over the next 12 months.
How has AUNA stock performed over the past year?
Auna SA returned -14.9% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Auna SA do?
Auna S.A. is a healthcare services company that operates integrated medical platforms across Latin America.
About Auna SA.
Auna S.A. is a healthcare services company that operates integrated medical platforms across Latin America. Headquartered in Luxembourg and founded in 2022, the company focuses on providing comprehensive healthcare and medical services through hospitals, clinics, and specialized care centers. Auna S.A. is organized into segments including Oncosalud Peru, which offers oncology-focused services and prepaid cancer care plans, and broader Healthcare Services in Peru and Colombia, which encompass general medicine, surgery, diagnostics, and outpatient care. The company serves individuals, families, and corporate clients through prepaid healthcare plans, membership models, and direct care, aiming to improve access to organized, network-based medical services. By combining clinical services with preventive care programs, diagnostics, and specialty treatments, Auna S.A. plays a notable role in the healthcare sector in its core markets, contributing to the region’s private healthcare infrastructure and offering alternatives to public health systems and traditional insurance-based care structures.
CEO Mr. Jesús Antonio Zamora Leon · 14,796 employees · Luxembourg · https://www.aunainvestors.com